Lipopolymers as the Basis of Non-Viral Delivery of Therapeutic siRNA Nanoparticles in a Leukemia (MOLM-13) Model
Small interfering RNA (siRNA) therapy in acute myeloid leukemia (AML) is a promising strategy as the siRNA molecule can specifically target proteins involved in abnormal cell proliferation. The development of a clinically applicable method for delivering siRNA molecules is imperative due to the chal...
Saved in:
Main Authors: | Panadda Yotsomnuk, Amarnath Praphakar Rajendran, Daniel Nisakar Meenakshi Sundaram, Luis Carlos Morales, Cezary Kucharski, Mohammad Nasrullah, Wanwisa Skolpap, Xiaoyan Jiang, Spencer B. Gibson, Joseph Brandwein, Hasan Uludağ |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/15/1/115 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The biogenesis, regulation and functions of transitive siRNA in plants
by: Tan Huijun, et al.
Published: (2024-09-01) -
Anionic liposomes prepared without organic solvents for effective siRNA delivery
by: Xiu Han, et al.
Published: (2023-05-01) -
Functions and applications of RNA interference and small regulatory RNAs
by: Feng Xuezhu, et al.
Published: (2024-11-01) -
siRNA therapeutics for effective management of rheumatoid arthritis
by: Vishakha R. Chakole, et al.
Published: (2025-01-01) -
A ROS-responsive hydrogel encapsulated with matrix metalloproteinase-13 siRNA nanocarriers to attenuate osteoarthritis progression
by: Qiuyang Wang, et al.
Published: (2025-01-01)